Transfer of different nonsteroidal antiinflammatory drugs via the lymphatic system in the rat

Drug Metabolism and Disposition

Volumn 24, Issue 10, 1996, Pages 1107-1110

  Oelkers, Rieke ^a   Ionac, Mihai ^a   Erb, Katharina ^a   Brune, Kay ^a   Geisslinger, Gerd ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 CARBOXYIBUPROFEN; 2 HYDROXYIBUPROFEN; 6 METHOXY 2 NAPHTHYLACETIC ACID; DRUG METABOLITE; IBUPROFEN; NABUMETONE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; TENOXICAM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG LYMPH LEVEL; LYMPHATIC SYSTEM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; LYMPHATIC SYSTEM; MALE; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0029992558     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. M. G. Johnston and J. L. Gordon: Regulation of lymphatic contractility by arachidonate metabolites. Nature 239, 294-297 (1981).
2. M. G. Johnston, A. Kanalec, and J. L. Gordon: Effects of arachidonic acid and its cyclooxygenase and lipoxygenase products on lymphatic vessel contractility in vitro. Prostaglandins 25, 85-98 (1983).
3. M. G. Johnston and C. Feuer: Suppression of lymphatic vessel contractility with inhibitors of arachidonic acid metabolism. J. Pharmacol. Exp. Ther. 226, 603-607 (1983).
4. C. T. Ueda, M. Lemaire, G. Gsell, and K. Nussbaumer: Intestinal lymphatic absorption of cyclosporin A following oral administration in an olive oil solution in rats. Biopharm. Drug Dispos, 4, 113-124 (1983).
5. J. Lamka, L. Rudisar, and J. Kvetina: On the limiting factors affecting the distribution of model drugs from blood into the lymphatic system. Eur. J. Drug Metab. Pharmacokinet. 3, 29 (1990).
6. M. G. Lowrimore, A. B. Porter, and A. Hume: Lymphatic and portal venous absorption of phenobarbital and thiopental in the dog. Arch. Int. Pharmacodyn. 288, 5-10 (1987).
7. L. S. Sudo, M. G. Almeida, W. Yasaka, and J. Garcia-Leme: Lymphatic transport of salicylates in dogs. Gen. Pharmacol. 20, 779-783 (1989).
8. E. F. Davies and G. S. Avery: Ibuprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic disorders. Drugs 2, 416-446 (1971).
9. J. P. Gonzalez and P. A. Todd: Tenoxicam: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 34, 289-310 (1987).
10. H. A. Friedel and P. A. Todd: Nabumetone: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases. Drugs 35, 504-524 (1988).
11. L. Shargel and A. B. C. Yu (eds.): "Applied Biopharmaceutics and Pharmacokinetics," 3rd ed., p. 127. Appleton & Lange, Norwalk, CT, 1993.
12. J. L. Bollman, J. C. Cain, and J. H. Grindlay: Techniques for the collection of lymph from the liver, small intestine and the thoracic duct of the rat. J. Lab. Clin. Med. 33, 1349-1352 (1948).
13. W. L. Frank, D. Stuhldreher, S. Muchnik, M. P. Shaw, B. Chou, M. Rubenstein, P. Ray, and P. Guinan: Microsurgical approach to the abdominal thoracic duct in the rat: considerations in the collection of lymphocytes. Microsurgery 13, 332-334 (1992).
14. R. Melarange, C. Gentry, M. Durie, C. O'Connell, and P. R. Blower: Gastrointestinal irritancy, antiinflammatory activity, and prostanoid inhibition in the rat. Dig. Dis. Sci. 39, 601-608 (1994).
15. P. A. Todd and R. N. Brodgen: Oxaprozin. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 32, 291-312 (1986).
16. W. A. Ritschel (ed.): "Handbook of Basic Pharmacokinetics," 3rd ed., pp. 71-75. Drug Intelligence Publications, Hamilton, Ontario, Canada, 1986.
17. G. Geisslinger, K. Dietzel, D. Loew, O. Schuster, G. Rau, G. Lachmann, and K. Brune: High-performance liquid chromatographic determination of ibuprofen, its metabolites and enantiomers in biological fluids. J. Chromatogr. 491, 139-149 (1989).
18. S. Menzel-Soglowek, G. Geisslinger, and K. Brune: Stereoselective high-performance liquid chromatographic determination of ketoprofen, ibuprofen and fenoprofen in plasma using a chiral AGP column. J. Chromatogr. 532, 295-303 (1990).
19. P. Heizmann, J. Körner, and K. Zinapold: Determination of tenoxicam in human plasma by high-performance liquid chromatography. J. Chromatogr. 374, 95-102 (1986).
20. SmithKline Beecham: Analysis of nabumetone and 6MNA in dialysate buffer from equilibrium dialysis of human plasma by reversed phase HPLC with fluorometric detection. 1992, Data on file.
21. J. E. Ray and R. O. Day: High-performance liquid chromatography determination of a new anti-inflammatory agent, nabumetone, and its major metabolite in plasma using fluorimetric detection. J. Chromatogr. 336, 234-238 (1984).
22. G. Heinzel, R. Woloszczak, and P. Thomann (eds.): "Topfit 2.0. Pharmacokinetic and Pharmacodynamic Data Analysis System." Gustav Fischer, Stuttgart, 1993.
23. M. Rowland and T. N. Tozer (eds.): "Clinical Pharmacokinetics. Concepts and Applications," 3rd ed. Williams & Wilkins, Baltimore, 1995.
24. J. Lamka, O. Jindrova, S. Gallova, R. Uhrova, and J. Kvetina: Influence of the composition of rat central lymph on the pharmacokinetics of diazepam, studied in the blood and lymph. Physiol. Bohemoslov. 39, 403-408 (1990).
25. N. P. Reddy: Lymph circulation. Physiology, pharmacology, and biomechanics. Crit. Rev. Biomed. Eng. 14, 45-91 (1986).
26. E. A. Meade, W. L. Smith, and D. L. DeWitt: Differential inhibition of prostaglandin endoperoxide synthetase (cyclooxygenase) isoenzymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268, 6610-6614 (1993).
27. J. Y. Jeremy, D. P. Mikhailidis, M. A. Barradas, R. M. Kirk, and P. Dandona: Effects of the prodrug nabumetone, and its active metabolite, 6-MNA, on human and rat gastric mucosal prostanoids and platelet function. Drugs 40 (Suppl. 5), 53-56 (1990).
28. C. Brideau, S. Kargman, S. Liu, A. L. Dallob, E. W. Ehrich, I. W. Rodger, and C. C. Chan: A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors. Inflamm. Res. 45, 68-74 (1996).
29. R. E. Girardet: Surgical techniques for long-term studies of thoracic duct circulation in the rat. J. Appl. Physiol. 39, 682-688 (1975).
30. S. G. Turner and J. A. Barrowman: Intestinal lymph flow and lymphatic transport of protein during fat absorption. Q. J. Exp. Physiol. Cogn. Med. Sci. 62, 175-180 (1977).